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Abstract 
Barramundi (Lates calcarifer), a catadromous teleost of significant and growing commercial 
importance, are reported to have limited fatty acid bioconversion capability, typical of marine 
species, and therefore require preformed long-chain polyunsaturated fatty acids (LC-PUFA) 
as dietary essential fatty acid (EFA). In this study, the response of juvenile barramundi (47.0 
g/fish initial weight) fed isolipidic and isoenergetic diets with 8.2% added oil was tested. The 
experimental test diets were either devoid of any fish oil (FO), and thus with no n-3 LC-
PUFA (FO FREE diet) or with a low inclusion of FO (FO LOW diet) and were compared 
against a control diet containing only FO (FO CTRL diet)as the added lipid source, over an 
eight week study period. Interim samples and measurements were taken every two weeks 
during the trial in order to define the onset and progression of the aetiology of EFA 
deficiency. After two weeks of feeding, the fish fed the FO FREE and FO LOW diets had 
significantly lower live-weights and after eight weeks significant differences were detected 
for all growth and feed utilisation parameters. The fish fed the FO FREE diet also had a 
significantly higher incidence of external abnormalities. Sub-clinical signs of deficiency were 
also noted in the plasma biochemistry with several parameters affected by dietary treatment. 
The transcription of several genes involved in fatty acid metabolism was affected after only 
two weeks of feeding with the experimental diets, showing a rapid nutritional regulation. This 
experiment documents the aetiology of the onset and the progression of EFA deficiency in 
juvenile barramundi and demonstrates that such deficiencies can be detected within two 
weeks in juvenile fish. 
  
Introduction 
Nutrient deficiency in any species can be difficult to determine accurately due to the 
difficulties in feeding a deficient diet. Early studies have specifically looked at fatty acid 
deficiency in fish (1) while others studying nutrient requirements have reached conclusions 
about deficiency signs and symptoms (2). There is a vast amount of literature on lipids and 
their constituent fatty acids in fish diets and a focal point has been on their complexity, 
uniqueness and biological importance (3). The barramundi or Asian sea bass (Lates 
calcarifer), are reported to have limited de novo capability to synthesise long-chain 
polyunsaturated fatty acids (LC-PUFA) (4, 5, 6). Moreover, the requirement of total lipid and 
LC-PUFA is thought to be low based on the compositional status of wild caught specimens 
compared to that of cultured barramundi (7, 8). 
Clinical signs of nutrient deficiency become an important indicator of fish health and 
productivity. If fish are fed a diet that is deficient in a particular nutrient that cannot be 
synthesised endogenously, then their physical condition will begin deteriorating once all body 
reserves become depleted or supply limits synthetic demands. Further, secondary 
pathological conditions may take hold as the animal’s immunity is compromised and without 
treatment premature death often follows. To avoid this situation arising, commercially 
produced feeds need to ensure an adequate supply of all essential nutrients, often achieved by 
the addition of fishmeal (FM) and fish oil (FO). However, global supply of these resources is 
under increasing environmental and economic pressure. Therefore it is important to 
determine critical inclusion levels of all essential nutrients in dietary formulations for 
cultured species. 
Several studies have induced essential fatty acid (EFA) deficiency in a range of fish species. 
One of the earliest was that of Castell et al. (1) who documented the feeding of rainbow trout 
(Oncorhynchus mykiss) over a prolonged time-course. These authors described a range of 
deficiency symptoms such as; poor growth, fin erosion, changing pigmentation, swollen 
livers and hearts and fainting or shock syndrome. A later study by Ruyter et al. (9) observed 
that Atlantic salmon (Salmo salar) exhibited poor growth, increased mortality and changed 
blood and liver condition after one month of feeding an EFA deficient diet. In other species 
such as channel catfish (Ictalurus punctatus) (10), red drum (Sciaenops ocellatus) (11), turbot 
(Psetta maxima) (12) and gilthead sea bream (Sparus aurata) (13), signs of EFA deficiency 
include a constant range of symptoms consistent with those described above, with the most 
prominent being reduced growth performance and survival. 
The precursors to LC-PUFA, linoleic acid (18:2n-6) and linolenic acid (18:3n-3) are 
considered essential or at least conditionally essential in all vertebrates, including fish, as 
they lack the desaturase enzymes required for their synthesis (14, 15). Typically, freshwater fish 
species, including the commercially important salmonids, can synthesise sufficient LC-PUFA 
from these precursor fatty acids to maintain biological function however most marine fish 
species have a pathway of fatty acid biosynthesis that is incomplete (15). Distinct differences 
also exist between the marine fish in their ability to convert precursor fatty acids to longer 
chain derivatives. Cultured cell lines of the marine fish turbot were used to demonstrate that 
elongation activity was limiting the conversion of 18:3n-3 to EPA (eicosapentaenoic acid, 
20:5n-3) whereas in gilthead sea bream delta-5 desaturase activity was limiting the 
conversion of 20:4n-3 to EPA (16, 17).  A recent study also concluded that barramundi (Lates 
calcarifer) lack significant delta-5 desaturase activity and are unable to convert 20:4n-3 to 
EPA, thus having an essential requirement for preformed dietary LC-PUFA including EPA, 
DHA (docosahexaenoic acid, 22:6n-3) and ARA (arachidonic acid; 20:4n-6) (6). Therefore, 
this supports that in vivo this species should succumb to EFA deficiency due to this inability 
to produce the reputedly required LC-PUFA. 
The lipid, and to a lesser degree the fatty acid requirements were examined in barramundi by 
a number of studies, yet there is still no clear documentation of the onset and progression of 
deficiency symptoms. Early studies demonstrated that performance of larval barramundi were 
improved by incorporating preformed long chain polyunsaturated fatty acid (LC-PUFA) into 
enriched live prey (18, 19). Other juvenile barramundi studies have reported signs of EFA 
deficiency such as abnormal reddening of the fins and reduced growth performance 
associated with low levels of  n-3 LC-PUFA (2, 20). More recently, Williams et al. (21) 
demonstrated improvements in barramundi productivity with increasing n-3 LC-PUFA at 
either 20 or 29˚C. Williams et al. (21) described a ‘fainting attack’ from a small number of 
their fish and this effect has also previously been observed in rainbow trout fed EFA deficient 
diets (1). Glencross and Rutherford (22) showed for the first time that barramundi performance 
was clearly affected by the presence or absence of certain EFA. These authors also reported 
symptoms such as reddening of the fins and the opercula region however this was attributed 
to increasing DHA in the absence of an equivalent increase of EPA. 
Among these results, it is clear that EFA play an important physiological role in both larval 
and juvenile barramundi while less is known about the effects on larger fish. Despite the 
efforts of numerous studies so far, there remains to be a clear analysis of the onset and 
clinical signs of EFA deficiency in barramundi. Therefore, the aim of this experiment was to 
document the aetiology of the onset of essential fatty acid deficiency in juvenile barramundi. 
It was hypothesised that once the endogenous reserves of LC-PUFA are progressively 
depleted then sub-clinical EFA deficiency symptoms will develop before further gross 
clinical signs become evident.  
 
Materials and methods 
Ingredient and diet preparation 
A single basal diet was formulated and prepared without the addition of dietary lipids. The 
dry ingredients were passed separately through a hammermill (Mikro Pulverizer, type 1 SH, 
New Jersey, USA) such that the maximum particle size was less than 750 µm. All dry 
ingredients were then thoroughly mixed using an upright commercial mixer (Bakermix, 
Model 60 A-G, NSW, Australia). Fish meal was defatted prior to use by manually mixing 
hexane and fish meal (2:1) in a large drum. The mix was left to soak for 3h before draining 
the excess hexane and repeating the process a second time. The fish meal was oven dried 
overnight at 60 ˚C to a constant dry matter. The chemical composition of the main dietary 
ingredients is presented in Table 1. The basal diet was then separated into smaller batches and 
aliquots of lipid (8.2% diet) were added to form the three treatment diets. Fresh water was 
added at approximately 30% of dry mash weight and mixed to form consistent dough then the 
dough was subsequently screw pressed through a 4 mm die. The pellets were dried overnight 
at 60 ˚C to a constant dry matter. The dietary treatments provided protein at 60%, lipid at 
13% with an energetic value of 22 MJ/kg. The three dietary treatments consisted of a control 
diet with added FO (designated as FO CTRL), a diet containing only 1% FO and a blend of 
olive and palm oil (designated as FO LOW) and a diet devoid of any FO and a blend of olive 
and palm oil (designated as FO FREE). The diets were then stored at -20 ˚C until required. 
The formulation and chemical composition of the three diets are presented in Table 2. 
Barramundi husbandry and growth 
Juvenile barramundi (Lates calcarifer) were sourced from the Betta Barra fish hatchery 
(Atherton, QLD, Australia), on-grown in a 10,000L tank and fed a commercial diet (Marine 
Float; Ridley Aquafeed, Narangba, QLD, Australia). Prior to commencement of the 
experiment the fish were transferred to a series of experimental tanks (300L) with flow-
through seawater (salinity =35 PSU; dissolved oxygen 4.6 ± 0.15 mg /L) of 30.0 ± 0.01 ºC 
(mean ± SD) at a flow rate of about 3 L/min being supplied to each of the tanks. At the 
beginning of the experiment, each of the tanks held 26 fish of 47.0 ± 0.3 g (mean ± SD, n = 
624 individually weighed fish). The three experimental diets were randomly distributed 
amongst the nine tanks with each treatment having three replicate tanks.  
Sample collection, preparation and digestibility analysis 
Ethical clearance was approved for the experimental procedures by the CSIRO animal ethics 
committee A10/2013. Six fish of similar size from the original stock were euthanized by an 
overdose of AQUI-S™ (Lower Hutt, New Zealand) at the beginning of the experiment and 
stored at -20 ºC until analysis. A further six fish were dissected and a sample of whole blood 
was removed from the caudal vein using 1 mL pre-heparinised syringes and an 18 G needle. 
Blood from three fish was pooled in a single Vacutainer™ tube and then centrifuged at 
10,000 rpm for 5 min to settle the erythrocytes. The plasma was then drawn off and 
transferred to a 1.5 mL Eppendorf™ tube and frozen ay -80 ˚C before being sent for analysis. 
A sample of liver tissue was then removed and placed into 1.5 mL screw-top vial and kept on 
dry ice before being transferred to a -80 ˚C freezer until analysis. All sampling procedures 
occurred 24 h post feeding (23). Interim samples of individual fish (n=3) were collected in the 
same fashion after each 14 d period and upon termination after 56 d and the remaining fish 
returned to their respective tank after a short recovery.   
Prior to the termination of the growth assay, faeces were collected using established 
settlement protocols (24) . Briefly, a collection chamber was filled with water and frozen then 
attached to the evacuation line of a swirl separator and left overnight. The following morning, 
the collection chamber was removed and the chilled faeces were captured in a plastic sample 
container and stored at -20 ˚C until analysis.  
Abnormalities and behaviour assessment 
The physical condition of individual fish was recorded at each fortnightly sampling event. 
Any fish that had symptoms such as erosion of the fins, reddening of the fins and extremities, 
gross lesions and physical deformities were recorded. These symptoms were pooled and a 
percentage score given to each tank and each tank was used as a replicate within each 
treatment. The behaviour of each tank of fish was assessed by an operator holding a hand 
over the corner of a tank to simulate commencement of a feeding event. Fish activity was 
scored as being either cryptic (0), ambivalent to the hand (1) or actively searching for food 
(2). This assessment was carried out prior to feeding on the same day of each week by the 
same operator to maintain consistency and the results were averaged across time to give a 
repeated measures response to each tank. Each tank was used as a replicate within each 
treatment (22). 
Chemical analysis 
Prior to analysis the diets were each ground to a fine powder using a bench grinder 
(KnifeTec™ 1095, FOSS, Denmark). The initial and final fish were processed using the 
following method. The whole fish were passed through a commercial meat mincer (MGT – 
012, Taiwan) twice to obtain a homogeneous mixture. A sample was taken for dry matter 
analysis and another sample was freeze-dried along with the faecal samples until no further 
loss of moisture was observed (Alpha 1-4, Martin Christ, Germany). Dry matter was 
calculated by gravimetric analysis following oven drying at 105ºC for 24 h. Total yttrium 
concentrations were determined after nitric acid digestion in a laboratory microwave digester 
(Ethos One, Milestone, Italy) using inductively coupled plasma-mass spectrophotometry 
(ICP-MS) (ELAN DRC II, Perkin Elmer, USA). Crude protein was calculated after the 
determination of total nitrogen by organic elemental analysis (CHNS-O Flash 2000, Thermo 
Scientific, USA), based on N x 6.25. Total lipid content was determined gravimetrically 
following extraction of the lipids using chloroform:methanol (2:1) following Folch et al. (25). 
Gross ash content was determined gravimetrically following loss of mass after combustion of 
a sample in a muffle furnace at 550 ˚C for 24 h. Gross energy was determined by adiabatic 
bomb calorimetry (Parr 6200 Calorimeter, USA).  
Samples of plasma were sent to the West Australian Animal Health Laboratories (South 
Perth, Western Australia) for plasma enzyme and chemistry assessment. The assays were run 
on an Olympus AU400 automated chemistry analyser (Olympus Optical Co. Ltd). Each of 
the assays used was a standard kit developed for the auto-analyser. The tests performed 
included alanine aminotransferase (ALT, EC 2.6.1.2) (Olympus kit Cat. No. OSR6107), 
creatine kinase (CK, EC 2.7.3.2) (Olympus kit Cat. No. OSR6179), glutamate 
dehydrongenase (GLDH, EC 1.4.1.2) (Randox kit Cat. No. GL441), total protein (Olympus 
kit Cat. No. OSR6132), creatinine (Olympus kit Cat. No. OSR6178), alkaline phosphatase 
(Olympus kit Cat. No. OSR6004), glucose (Olympus kit Cat. No. OSR6121) and haem 
(Randox test kit Cat. No. HG1539). Trace elements were determined after mixed acid 
digestion using inductively coupled plasma mass spectrometry (ICP-MS).  
Fatty acid composition was determined following the methods of Christie (26). Lipids were 
esterified by an acid-catalysed methylation and 0.3 mg of an internal standard was added to 
each sample (21:0 Supelco, PA, USA). The fatty acids were identified relative to the internal 
standard following separation by gas chromatography (GC). An Agilent Technologies 6890N 
GC system (Agilent Technologies, California, USA) fitted with a DB-23 capillary column 
and flame ionisation detection was used. The temperature program was 50–175 ºC at 25 ºC 
/min then 175–230 ºC at 2.5 ºC /min. The injector and detector temperatures were set at 250 
ºC and 320 ºC, respectively. The carrier gas was hydrogen at a flow rate of 40 mL/min. The 
peaks were identified by comparing retention times to the internal standard and further 
referenced against known standards (37 Comp. FAME mix, Supelco, PA, USA). The 
resulting peaks were then corrected by the theoretical relative FID response factors (27) and 
quantified relative to the internal standard. 
RNA extraction and normalisation 
Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer’s 
instructions. RNA was precipitated using equal volumes of precipitation solution (1.2 M 
sodium chloride and 0.8 M disodium citrate) and isopropyl alcohol (28). To eliminate any 
residual traces of DNA, total RNA was DNase digested with the Turbo DNA free kit 
(Applied Biosystems). To verify that RNA was not contaminated, an aliquot of DNase 
digested RNA from each sample was pooled (n=54) and later PCR amplified as a negative 
control. A NanoDrop spectrophotometer (NanoDrop Technologies) was used asses RNA 
quantity and a Bioanalyser (Agilent Technologies) using RNA nanochips (Agilent #5067-
1511) was used to asses RNA quality. All RNA samples were normalised to 200 ng/µl. 
Quantitative real time RT-PCR 
Reverse transcription was performed on 1 µg of total RNA using Superscript III (Invitrogen) 
with 25 µM oligo (dT)20 and 25 µM random hexamers 
(29). Expression of a range of genes 
involved in fatty acid metabolism was analysed by real-time PCR as described below. Real-
time PCR amplification reactions were carried out using 1X SYBR Green PCR Master Mix 
(Applied Biosystems), 0.2 µM of Real-Time PCR primers specific to each gene (Table 3) and 
the equivalent of 7.5 ng of reverse-transcribed RNA. Amplification cycle conditions were 2 
min at 50 ˚C, 10 min at 95 ˚C followed by 40 cycles of 15 s at 95 ˚C and 40 s at 60 ˚C. After 
amplification, a melt curve analysis was routinely performed to verify the specificity of the 
target gene. Reactions were setup using the epMotion 5070 robot (Eppendorf) and run in 
triplicate on a Viia7 real-time PCR system (Applied Biosystems). Changes in expression 
levels of each gene over the eight week trial (denoted WK0, WK2, WK4, WK6 and WK8) 
were determined by normalising the cycle threshold values for each gene to elongation factor 
1 alpha (EF1α) and Luciferase reference genes, then to the cycle threshold of each gene at 
time zero (WK0). The variation in amplification of EF1α was 1.24 cycles and Luciferase was 
0.58 cycles and this did not significantly change over time. The EF1α and Luciferase genes 
are routinely used as a reference in this species (23, 30). 
Calculations and statistical analysis 
Differences in the ratio of dry matter, protein, lipid and energy to yttrium in the diet and 
faeces were calculated to determine the apparent digestibility coefficients (ADC) following 
Maynard and Loosli (31).  Nutrient retention efficiencies were calculated as the ratio of the 
nutrient or specific fatty acid gained relative to their respective consumption during the study 
period following Maynard and Loosli (31). The computation of apparent in vivo fatty acid β-
oxidation was performed using the whole body fatty acid balance method (WBFABM) 
following Turchini et al. (32). 
All data were checked for normal distribution and homogeneity of variance by qualitative 
assessment of residual and normal Q-Q plots using the RStudio package v.0.98.501 (33). All  
performance data were analysed by one-way analysis of variance (ANOVA) using the 
RStudio package v.0.98.501 (33). Live-weight data were analysed by analysis of covariance 
(ANCOVA) between the week two and week eight measurements using the RStudio package 
v.0.98.501(33). Gene expression data were analysed by t-test. Any percentage data were 
arcsine transformed prior to analysis. Levels of significance were compared using Tukey’s 
HSD a posteriori test with significance among treatments defined as P < 0.05.  
 
Results 
Growth and feed utilisation 
During the 56 d growth assay, the fish responded readily to the experimental diets and growth 
in the control group was consistent with the predicted model growth, achieving 106% of the 
modelled potential (34). When analysed by ANOVA there was a significant difference in live-
weight after two weeks of feeding on the experimental diets, with the fish fed the FO LOW 
and FO FREE diets being smaller from those fed the FO CTRL diet. By six weeks of feeding 
there was a significant difference among all three groups of fish and this remained the same 
at eight weeks. The same results were found with weight gain. When the live-weight data 
were analysed by ANCOVA there was a significant effect of the diets after controlling for 
week two measurements (F=1739, df 5,30, P<0.001). There was no difference in feed intake 
among the groups of fish however there was a significant difference in FCR between the FO 
CTRL and FO FREE fed fish (Table 4). There were no differences in terms of survival with 
only one fish removed from the system. 
The total lipid was significantly more digestible in the FO CTRL fed fish than the FO FREE 
fed fish (Table 5). There were several significant differences in specific fatty acid 
digestibility. The n-3 LC-PUFA including EPA and DHA were all completely digested by the 
fish fed FO LOW and FO FREE diets whereas the FO CTRL fed fish digested less of these 
fatty acids (Table 5). Although significant, the numerical differences were minor. The 
digestibility of total saturated fatty acids (SFA) was significantly different with fish fed the 
FO FREE diet able to digest more than the fish fed the FO CTRL diet.  
Biochemical analysis 
There were significant differences in macro nutrient retention of the fish after eight weeks of 
feeding with the control fed fish retaining more protein, lipid and gross energy than the FO 
LOW and FREE fed fish (Table 4). Generally, the fatty acid composition of the diets was 
reflected in the whole fish and also the liver tissue (Table 6). There were significant 
differences in most of the dominant fatty acids in the whole-body with the only exceptions 
being 18:3n-3 and 16:0 (Table 6). Similarly, in the liver, there were significant differences in 
most of the dominant fatty acids with the exception of 18:2n-6, 18:3n-3 and 16:0 (Table 6).  
After eight weeks, there was a significant decrease in the retention of SFA, MUFA and 
PUFA in the FO LOW and FO FREE fed fish compared to the FO CTRL fed fish while the 
LC-PUFA retention was highest in the FO LOW fed fish (Figure 1). In terms of calculated β-
oxidation values there was significantly less oxidation of total SFA and MUFA in the FO 
CTRL fed fish. There was no difference in PUFA oxidation however significantly more LC-
PUFA was oxidised in the FO CTRL fed fish (Figure 1).  
Clinical observations 
A range of abnormalities were observed during the experiment. These included red fins 
(typically caudal and pectoral), red skin, fin erosion, lesions and non-contributing (feed 
refusal) fish. The fish fed the FO FREE diet were significantly more affected by a range of 
abnormalities than the fish fed the FO LOW and FO CTRL diets (Table 4). There was no 
significant difference in the behavioural response of fish assessed by the methods described 
earlier (Table 4).  
Sub-clinical parameters 
A range of plasma chemistry parameters were assessed and some significant differences were 
observed among the dietary treatments (Figure 2). Only those parameters with significant 
differences are reported. There was a significant time effect on alanine aminotransferase 
(ALT) activity among the dietary groups decreasing dramatically from the initial level until 
week four and increasing thereafter. Creatine kinase (CK) activity were affected by time in a 
similar fashion to that of ALT however the FO FREE fish levels did not increase beyond four 
weeks which lead to a significant diet effect. Plasma cholesterol was significantly elevated in 
the FO CTRL fish at each time point. There was a significant diet and time effect on the 
glutamate dehydrogenase (GLDH) activity, decreasing from the initial sample until week six 
then rapidly rising in the FO LOW and FO FREE groups. There was an effect between the 
diets over time on the haemoglobin levels leading to a significantly lower level in the FO 
FREE fed fish at the final sample. There was also a significant time effect on haptoglobin 
with levels rapidly rising between the sixth and final sampling events. Similarly, the plasma 
magnesium level increased between the sixth and final sampling event and urea decreased 
following the initial sample however it gradually increased after each consecutive sampling 
event.  
Expression of lipid metabolism related genes in the liver of the FO CTRL and FO FREE fish 
were analysed by real-time quantitative PCR and several significant differences were 
observed (Figure 3). There was no significant diet effect for CPT1a and ELOVL5. There was 
a significant diet effect on the expression of ACYL with the highest expression in the FO 
FREE fed fish at week four. Similarly, the expression of FAS was approximately 2.5-fold 
higher in the FO FREE fish after two weeks of feeding and significant differences were 
observed at each time point. Similarly, the expression of SCD was significantly affected at 
each time point by the dietary treatment with levels of expression in the FO FREE fish 
approximately 3- to 4-fold higher than the FO CTRL fish. There was a significant difference 
in the expression of FADS2 at each sampling time point with approximately 2-fold higher 
expression among the FO FREE fed fish.  
 
Discussion 
The onset of EFA deficiency on growth and feed utilisation in juvenile barramundi was 
evident after only two weeks of feeding the experimental diets. After eight weeks growth was 
clearly different among all three groups suggesting that a primary feature of EFA deficiency 
is growth potential. In addition, there was strong evidence of a difference in the rate of live-
weight change between the diet treatments showing a clear progression towards EFA 
deficiency. This is in agreement with other studies showing reduced growth when 
carnivorous marine fish were fed with high levels of FO substitution (35, 36, 37). In addition, 
consistent with the maintenance of feed intake but with reduced growth, the feed conversion 
of FO FREE fed fish was significantly poorer. The ability to define a response to a nutrient 
relies on being able to define any symptoms that may occur in its absence. The defatted fish 
meal used in the present study contained trace amounts of lipid and LC-PUFA. However, the 
inclusion of 15% defatted fish meal was based on previous recommendations to achieve what 
is considered normal growth for this species (34, 38).  
Early studies with barramundi demonstrated that decreased dietary lipid is associated with 
reduced growth and in some cases EFA deficiency was inferred (2, 20, 21, 39). In the present 
study, the macro nutrient levels were kept constant as barramundi, like most other species, 
have an interdependent demand for energy and specific nutrients (40). The total lipid level was 
formulated to be lower than the known optimal requirement (>14%) for fish of this size 
(<100 g) so that in this experimental design the lipid would theoretically be limiting and 
therefore cause the supply of this nutrient (and vagaries in its composition) to be the point of 
sensitivity in the study (40). Therefore, the differences in the present study are directly 
attributable to the fatty acid profile of the diets, resulting in EFA deficiency.  
In the present study, the digestibility of total lipid was lowest in the FO FREE fed fish 
consistent with other studies investigating FO replacement (41, 42, 43). The apparent digestibility 
of specific fatty acids was not greatly modified by the dietary treatments with the exception 
of the saturated fatty acids. In the study of Olsen et al. (44), 18:0 was reported to be less 
digestible than other saturates such as 16:0 and 14:0 and in agreement, the reduction of total 
lipid digestibility of the present study is likely to be caused by the 18:0 composition of the 
feeds. Several studies have concluded that changes in lipid or fatty acid digestibility can 
result in reduced growth (45, 46, 47) whereas others have found no such effect (41, 42). The whole-
body and liver fatty acid profiles in the present study showed some clear differences in terms 
of their composition, however the tissue composition largely resembled that of the fed diet, 
also consistent with other studies (48, 49, 50).  A caveat of the present study was that the initial 
EFA composition of the fish was reflective of the commercial diet fed prior to 
experimentation. There was a slight reduction of total SFA in the whole body and a lack of 
any change in the liver, despite the different digestibility values and growth. Moreover, the 
LC-PUFA composition of the tissues in the FO FREE fed fish was almost entirely depleted 
after eight weeks suggesting that the reduced digestibility of total SFA had no bearing on the 
overall composition of the fish.  
Examination of the mass-balance relationship of dietary nutrients or indeed specific fatty 
acids in the tissues was used reveal discrete differences in their utilisation. Improved protein 
retention and consequently weight gain was evident in the control group, consistent with 
previous studies on barramundi (21). The disproportionately low lipid and energy retention of 
the FO LOW and FO FREE fed fish is a response to the diets without adequate LC-PUFA. 
The FO CTRL fed fish, selectively retained more of the dietary SFA, MUFA and PUFA than 
the other fish however LC-PUFA were catabolised when in surplus to optimal tissue 
concentration, similar to observations from other carnivorous species such as Atlantic 
salmon, European sea bass, Murray cod and rainbow trout (48, 51, 52, 53).  
The aetiology of deficiency was less apparent in the FO LOW fed fish. The total LC-PUFA 
concentration in the FO LOW diet with 1% added FO was equivalent to 4.3 g/kg of the diet 
compared to 25.6 g/kg in the control diet. Currently available requirement data for 
barramundi suggest that an adequate dietary LC-PUFA supply should be at least 12 g/kg in 
growing barramundi (21). In agreement, Glencross and Rutherford (22) reasoned that provided 
EFA are kept in balance the total LC-PUFA requirement could be further revised. Despite the 
very low inclusion of LC-PUFA (FO LOW and FO FREE diets) there were no apparent 
effects of the diets on survival or behavioural changes. However, a range of physical 
abnormalities were observed in the FO FREE fed fish including; erosion of the fins, 
reddening of the fins and extremities, gross lesions and physical deformities, symptoms 
which are associated with EFA deficiency in fish (1). This observation suggests that even at 
very low inclusion levels of FO there was a marked improvement in the physical health of 
fish despite the reduced growth. Moreover, the whole-body composition data suggest that the 
FO LOW fed fish maintained a proportion of LC-PUFA similar to that of the initial fish fed a 
commercially available diet. Therefore in support of the previous studies on this species, we 
too support that it is possible to reduce the LC-PUFA to levels below 12 g/kg without 
pathological evidence of EFA deficiency however below this level is not considered adequate 
to support ideal growth of the fish. 
 
A range of plasma biochemical markers were used to assess the aetiology of EFA deficiency 
over the eight week time course. The results suggest that aminotransferase activity, including 
glutamate dehydrogenase (GLDH) and alanine aminotransferase (ALT), generally increased 
after six weeks in the EFA deficient fish. Consistent with other species, GLDH activity in 
barramundi is considered a reliable marker of liver cell necrosis which can be also 
characterised by the depletion of hepatic LC-PUFA stores (54, 55). In addition, elevated 
creatine kinase (CK) activity levels, indicative of muscle damage and often linked to 
myocardial infarction (56), also increased after six weeks in the FO CTRL and FO LOW fish. 
Similarly, plasma magnesium and urea, a marker for renal dysfunction which has been 
related to EFA deficiency (57), responded in much the same fashion. Both haemoglobin and 
haptoglobin showed a similar response where levels increased after six weeks. The same 
effect has been linked to a mild anemia in rainbow trout (58). The plasma markers are 
consistently affected after six weeks of feeding which potentially indicates a point of 
sensitivity for the dilution of body EFA reserves in barramundi. This suggests that a temporal 
scale is an important consideration in defining the aetiology of EFA deficiency in 
barramundi. Other studies found no difference in growth performance parameters after 
feeding a deficient diet for four weeks (59) or six weeks (22), while longer term studies 
demonstrated clear signs of EFA deficiency, including changes in plasma biochemistry, with 
rainbow trout after 18 weeks (58) and with Atlantic salmon between 12 -16 weeks (9).   
Consistent with other studies, nutritionally regulated gene expression in the FO CTRL fed 
fish appear to follow a normal progression of desaturation and elongation of FA to their 
longer chain and less-saturated derivatives (6, 23, 60). In the present study, there was no 
significant diet effect in the expression of elongation (ELOVL5), ATP citrate lyase (ACYL) 
or carnitine palmitoyltransferase (CPT1a) however there was a tendency towards higher 
expression in the FO FREE fed fish. Similarly, Araujo et al. (60) found that there was a 
tendency towards higher expression of each of these genes in barramundi fed a FO deficient 
diet. Mixed results from previous studies have shown that CPT1a expression can be down 
regulated in response to vegetable oils (61) whereas others have shown an up-regulation (62).  
This study and that of Araujo et al. (60) found that steroyl CoA desaturase (SCD) expression 
in barramundi was significantly up-regulated in fish fed a FO deficient diet as they attempt to 
convert available stearic acid to more energetically available oleic acid. Moreover, in 
agreement with other studies, on a range of species, the expression of desaturase enzymes 
(including both SCD and FADS2) increased in response to reduced FO (60, 63, 64, 65, 66). Fatty 
acid synthase (FAS) expression in the present study was also significantly up-regulated in 
fish fed the FO FREE diet. Although the FAS enzyme system has rarely been investigated in 
fish in response to FO replacement, it is an important step in the initial synthesis of palmitate 
from acetyl-CoA.  
Conclusions 
In conclusion, the results of this study report comprehensively the aetiology of the onset and 
progression of EFA deficiency in barramundi. The EFA deficient diets clearly impacted 
growth performance and feed utilisation in as little as two weeks. Discrete differences in the 
utilisation of dietary lipid and also specific fatty acids suggest that in the absence of EFA, 
signs of deficiency were evident substantiating its essentiality in barramundi. In addition, a 
range of clinical abnormalities manifested in the fish fed the FO FREE diet. Sub-clinical 
diagnostics of plasma biochemistry and gene expression consistently demonstrated the 
negative effect on those fish receiving the FO FREE and in some cases FO LOW diet and 
these appeared to occur after six weeks of feeding, lending support to the hypothesis that 
assessment on a temporal basis is critical in fatty acid studies on fish. 
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Figure legends 
Figure 1 (a-d) Mass-balance computations of fatty acid retention and β-oxidation in juvenile 
barramundi, mean (SEM) n=3. Saturated fatty acid (a; SFA) retention F=82.5***, β-oxidation 
F=5.2*; Monounsaturated fatty acid (b; MUFA) retention F=44.5***, β-oxidation F=7.0*; 
Polyunsaturated fatty acid (c; PUFA) retention F=10.8*, β-oxidation F=1.4, P=0.32; Long-
chain polyunsaturated fatty acid (d; LC-PUFA) retention F=6.1*, β-oxidation F=241.5***. 
Significant differences are indicated by a star (*, P<0.05; **, P<0.01; ***, P<0.001), one –
way ANOVA df 2,6., post-hoc Tukey’s HSD. 
Figure 2 (a-h) Plasma chemistry parameters of juvenile barramundi. Different symbols 
represent ○ FO CTRL ● FO LOW Δ FO FREE treatment diets, mean (SEM) n=3. Significant 
differences at each time point are indicated by a star (*, P<0.05; **, P<0.01; ***, P<0.001), 
one–way ANOVA df 2,6. 
Figure 3 (a-f) Expression of lipid metabolism genes in the liver of juvenile barramundi. All 
data are normalised to EF1α and Luc reference genes, log 2 transformed and expressed 
relative to the initial fish (WK 0), mean (SEM) n=3. The FO CTRL (control) groups are 
indicated by light bars and the FO FREE groups are indicated by dark bars. Significant 
differences are indicated by a star (*, P<0.05; **, P<0.01; ***, P<0.001) above a sampling 
point, two-tailed t-test df 10. Lc ACYL, Lates calcarifer ATP citrate lyase; Lc CPT1a, L. 
calcarifer carnitine palmitoyltransferase; Lc FAS, L. calcarifer fatty acid synthase, Lc SCD, 
L. calcarifer steroyl CoA desaturase, Lc ELOVL5, L. calcarifer fatty acid elongation 5; Lc 
FADS2, L. calcarifer fatty acid desaturase 6. 
  
Table 1 Chemical composition of ingredients used in experimental diets, all values are g/kg unless otherwise stated.  
    
Fish 
meal# 
Poultry 
meal 
Soy 
isolate 
Wheat 
gluten 
Wheat 
flour Casein 
Wheat 
starch 
Fish 
oil 
Olive 
oil 
Palm 
oil 
Palm 
flake 
Composition                       
  Dry matter 984 958 958 927 839 924 836 992 987 999 994 
  Protein 789 641 895 823 112 870 5 4 4 3 4 
  Ash 163 138 46 1 6 11 3 1 ND ND ND 
  Lipid 46 151 57 55 22 5 1 956 973 963 986 
  Carbohydrate 2 70 2 121 860 113 992 39 23 34 10 
  Gross energy (MJ/kg) 18.9 20.4 21.8 21.2 15.3 21.9 14.5 39.3 39.5 39.5 39.3 
                          
Fatty acids (%) ^                       
  Total FA (mg/g lipid) 625.0 638.8 - - - -  -  596.4 879.5 867.8 749.8 
  22:6n-3 19.9 ND - - - - - 14.2 ND ND ND 
  22:5n-3 2.2 ND - - - - - 2.1 ND ND ND 
  20:5n-3 9.0 0.5 - - - - - 11.3 ND ND ND 
  20:4n-6 2.5 0.6 - - - - - 1.5 ND ND ND 
  18:3n-3 0.8 1.0 - - - - - 1.0 1.0 ND ND 
  18:2n-6 1.7 11.0 - - - - - 2.0 11.0 6.7 ND 
  18:1 15.5 43.8 - - - - - 18.6 73.8 34.6 0.4 
  18:0 8.7 8.6 - - - - - 5.1 3.0 4.6 51.3 
  16:0 25.8 25.4 - - - - - 22.9 9.9 51.9 46.2 
  SFA 39.8 36.1 - - - - - 36.4 13.4 58.6 99.6 
  MUFA 22.2 50.8 - - - - - 29.1 74.6 34.7 0.4 
  PUFA 3.4 12.0 - - - - - 4.9 12.0 6.7 ND 
  LC-PUFA 34.5 1.2 - - - - - 29.7 ND ND ND 
  Total n-3  32.7 1.6 - - - - - 30.5 1.0 ND ND 
  Total n-6 5.2 11.6 - - - - - 4.1 11.0 6.7 ND 
Any values <0.01 are reported as 0.1; NA, Not analysed; ND, Not detected 
# Fish meal was defatted using hexane.  
 ^ All fatty acids are presented as a percentage of the total fatty acids. Quantitative data can be obtained by multiplying the total FA (mg/g lipid) 
by specific fatty acids (%).  18:1, sum of 18:1n-7, 18:1n-9 cis, 18:1n-9 trans; saturated fatty acids (SFA), sum of 12:0, 14:0, 16:0, 18:0, 20:, 22:0, 
24:0; monounsaturated fatty acids (MUFA), sum of14:1n-5, 16:1n-7, 18:1n-7, 18:1n-9 (cis and trans), 20:1n-7, 20:1n-9, 22:1n-9, 24:1n-9; 
polyunsaturated fatty acids (PUFA), sum 18:2n-6 (cis and trans), 18:3n-6, 18:3n-3, 18:4n-3; long chain polyunsaturated fatty acids (LC-PUFA), 
sum 20:2n-6, 20:3n-6, 20:4n-6, 22:4n-6, 2-:3n-3, 20:5n-3, 22:5n-3, 22:6n-3; n-3, sum of omega 3 PUFA and LC-PUFA; n-6, sum of omega 6 
PUFA and LC-PUFA.
Table 2 Formulation and composition of experimental diets, all values are g/kg unless otherwise 
stated. 
    FO CTRL FO LOW FO FREE 
Formulation       
  Defatted fish meal a 150 150 150 
  Poultry meal a 150 150 150 
  Soy protein isolate b 150 150 150 
  Wheat gluten b 150 150 150 
  Wheat flour b 109 109 109 
  Casein c 100 100 100 
  Pregelled wheat starch 80 80 80 
  DL-Methionine 10 10 10 
  Di-calcium phosphate 10 10 10 
  Pre-mix vitamins d 8 8 8 
  Yttrium oxide e 1 1 1 
  Fish oil a 82 10 0 
  Olive oil f 0 36 41 
  Palm Oil f 0 18 20 
  Palm Flake f 0 18 20 
Composition       
  Dry matter 940 939 945 
  Protein 598 588 603 
  Ash 64 64 66 
  Lipid 126 123 122 
  Carbohydrate 204 219 202 
  Gross energy (MJ/kg) 21.5 21.3 21.6 
Fatty acids (% total) ^       
  Total FA (mg/g lipid) 681.8 708.4 717.4 
  22:6n-3 10.6 2.0 0.9 
  22:5n-3 1.6 0.1 0.1 
  20:5n-3 8.1 1.3 0.5 
  20:4n-6 1.2 0.3 0.1 
  18:3n-3 1.3 1.1 1.0 
  18:2n-6 10.0 13.0 13.2 
  18:1 22.7 38.8 41.1 
  18:0 5.5 11.9 12.6 
  16:0 22.9 27.0 27.6 
  SFA 34.5 41.2 41.8 
  MUFA 31.3 41.1 42.5 
  PUFA 12.7 14.1 14.3 
  LC-PUFA 21.5 3.7 1.4 
  Total n-3  22.9 4.4 2.4 
  Total n-6  11.3 13.4 13.2 
 
^ Please refer to Table 1 for details. 
a Ridley aquafeeds, Narangba, QLD, Australia. Fish meal defatted with hexane (see methods) 
b Manildra Group, Rocklea, QLD, Australia 
c Bulk Powders, www.bulkpowders.com.au  
d Vitamin and mineral premix (g/kg of premix): vitamin A, 0.75 mg; vitamin D3, 6.3 mg; 
vitamin E, 16.7 g; vitamin K3, 1.7 g; vitamin B1, 2.5 g; vitamin B2, 4.2 g; vitamin B3, 25 g; 
vitamin B5, 8.3 g; vitamin B6, 2.0 g; vitamin B9, 0.8 g; vitamin B12, 0.005 g; biotin, 0.17 g; 
vitamin C, 75 g; choline, 166.7 g; inositol, 58.3 g; ethoxyquin, 20.8 g; copper, 2.5 g; ferrous iron, 
10.0 g; magnesium, 16.6 g; manganese, 15.0 g; zinc, 25.0 g 
e Yttrium oxide; Stanford Materials, Aliso Viejo, California, United States  
f Sydney Essential Oil Co. (Sydney, NSW, Australia) 
Any values <0.01 are reported as 0.1; NA, Not analysed; ND, Not detected 
  
 Table 3 Real-time qPCR primer pairs for target genes involved in fatty acid metabolism.   
Target gene Abbreviation EC number Primer name Sequence Length 
Fatty acid metabolism           
  Fatty acid synthase Lc FAS EC 2.3.1.85 FAS qPCR.For 1 TGAATCTCACCACGCTTCAG 20 
        FAS qPCR.Rev 1 AGGCAGCAATAGAACCCTCA 20 
  Steroyl CoA desaturase Lc SCD EC 1.14.19.1 SCD qPCR.For 1 CCTGGTACTTCTGGGGTGAA 20 
        SCD qPCR.Rev 1 AAGGGGAATGTGTGGTGGTA 20 
  Carnitine palmitoyltransferase Lc CPT1a EC 2.3.1.21  CPT1A qPCR.For 1 TGATGGTTATGGGGTGTCCT 20 
        CPT1A qPCR.Rev 1 CGGCTCTCTTCAACTTTGCT 20 
  ATP citrate lyase Lc ACYL EC 2.3.3.8 Lcal ACYL F1 CAACACCATTGTCTGTGCTC 20 
        Lcal ACYL R1 GAAATGCTGCTTAACAAAGTCC 21 
  Fatty acid elongation 5 Lc ELOVL5 EC 2.3.1.n8   Lcal ELOVL5 F1 ATCCAGTTCTTCTTAACCGT 20 
        Lcal ELOVL5 R1 GGTTTCTCAAATGTCAATCCAC 22 
  Fatty acid desaturase 6 Lc FADS2 EC 1.14.19.- Lcal FADS2 F1 TCATACTACCTTCGCTACTTCTC 23 
        Lcal FADS2 R1 ACAAACCAGTGACTCTCCAG 20 
Reference           
  Luciferase Luc Na Luc qPCR F GGTGTTGGGCGCGTTATTTA 20 
        Luc qPCR R CGGTAGGCTGCGAAATGC 18 
  Elongation factor 1 alpha EF1α Na Lcal EF1α F AAATTGGCGGTATTGGAAC 19 
        Lcal EF1α R GGGAGCAAAGGTGACGAC 18 
 Table 4 Growth performance and feed utilisation of barramundi fed experimental diets for 
eight weeks. 
  FO CTRL FO LOW FO FREE P SEM ANOVA 
Live-weight initial (g) 46.9 46.9 46.8 0.07 F=0.1, P=0.89 
Live-weight WK2 (g) 92.7b 85.8a 87.4a 1.18 F=10.8* 
Live-weight WK4 (g) 139.2b 130.6a 125.9a 2.07 F=23.7** 
Live-weight WK6 (g) 185.0c 173.9b 162.9a 3.40 F=22.3** 
Live-weight WK8 (g) 238.3c 218.9b 202.8a 5.26 F=44.6*** 
Gain (g/fish) 191.4c 172.1b 156.0a 5.24 F=48.7*** 
Feed intake (g/fish) 209.6 196.3 207.9 3.91 F=1.2, P=0.36 
FCR 1.10a 1.14ab 1.33b 0.04 F=11.7 ** 
Protein retention (%) 34.1a 30.3b 27.8b 1.01 F=13.7 ** 
Lipid retention (%) 74.8a 61.7a 44.8b 4.61 F=24.2 ** 
Energy retention (%) 37.8a 34.5a 29.8b 1.30 F=11.4 ** 
Survival (%) 98 100 100 0.01 NA 
Abnormalities (%) 4.0a 2.0a 41.0b 0.08 F=6.8* 
Behaviour index 1.9 1.7 1.8 2.8 F=4.0, P=0.08 
P SEM, Pooled standard error mean, FCR, Feed conversion ratio 
P<0.001***  P<0.01**  P<0.05* 
One-way ANOVA df 2,6, post-hoc Tukey's HSD         
Percentage data were arcsine transformed prior to analysis        
Any values <0.01 are reported as 0.1; NA, Not analysed; ND, Not detected    
 
  
 Table 5 Apparent digestibility of macro nutrients and fatty acids present in the 
experimental diets. 
    FO CTRL 
FO 
LOW FO FREE P SEM ANOVA 
Dry matter (%)  64.3 70.8 65.4 1.5 
F=4.3, 
P=0.10 
Protein (%)  91.6 93.0 94.1 0.4 
F=4.4, 
P=0.08 
Total lipid (%)   90.7a 87.1ab 84.6b 1.5 F = 8.1 * 
Energy (%)  87.3 85.7 88.7 0.7 
F=2.4, 
P=0.19 
22:6n-3 (%)  98.5 100.0 100.0 0.6 NA 
22:5n-3 (%)  100.0 100.0 100.0 0.0 NA 
20:5n-3 (%)  99.0 100.0 100.0 0.2 NA 
20:4n-6 (%)  100.0 100.0 100.0 0.0 NA 
18:3n-3 (%)  98.6 100.0 100.0 0.6 NA 
18:2n-6 (%)  95.8 96.0 95.6 0.6 
F=0.2, 
P=0.84 
18:1 (%)  92.1 93.9 92.9 0.6 
F=1.6, 
P=0.30 
18:0 (%)  76.7a 70.9ab 65.6b 2.6 F=9.4* 
16:0 (%)  81.5 77.0 73.7 2.1 F=4.7, P=0.9 
SFA (%)  82.3a 76.0ab 71.8b 2.4 F = 8.0 * 
MUFA (%)  92.6 94.0 92.8 0.5 
F=1.1, 
P=0.41 
PUFA (%)  96.5 96.3 96.0 0.6 
F=0.5, 
P=0.66 
LC-PUFA (%)  98.9 100.0 100.0 0.4 NA 
Total n-3 (%)  98.9 100.0 100.0 0.4 NA 
Total n-6 (%)  96.3 96.1 95.6 0.5 
F=0.5, 
P=0.64 
P SEM, Pooled standard error mean         
P<0.001***  P<0.01**  P<0.05*       
One-way ANOVA df 2,6, post-hoc Tukey's HSD     
Percentage data were arcsine transformed prior to analysis  
Any values <0.01 are reported as 0.1; NA, Not analysed; ND, Not detected 
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Table 6 Initial and final fatty acid composition of whole-body and liver tissue from juvenile barramundi. All data are presented as percentage of total fatty acids 
(%) unless otherwise stated. 
   Whole-body        Liver         
  Initial 
FO 
CTRL 
FO 
LOW 
FO 
FREE 
P 
SEM ANOVA Initial 
FO 
CTRL 
FO 
LOW 
FO 
FREE 
P 
SEM ANOVA 
Total lipid (wet 
weight %) 5.1 9.5 9.4 8.7 0.2 F=2.9, P=0.14 NA NA NA NA NA NA 
Total FA (mg/g 
Lipid) ^ 681.0 616.6a 777.2b 729.6ab 25.8 F=17.4 ** NA NA NA NA NA NA 
22:6n-3 2.1 5.5a 2.0b 1.3c 0.7 F=39.2 *** 4.4 4.8a 2.2b 0.9c 0.6 F=202.2 *** 
22:5n-3 0.8 1.6a 0.7b 0.1c 0.2 F=88.9 *** 1.1 1.4a 0.5b 0.3c 0.2 F=167.2 *** 
20:5n-3 1.4 3.7a 1.0b 0.6b 0.5 F=70.4 *** 1.7 2.7a 0.7b 0.2c 0.4 F=440.8 *** 
20:4n-6 0.4 0.7a 0.1b 0.1b 0.1 F=34.5 *** 0.7 0.8a 0.5b 0.2c 0.1 F=94.9 *** 
18:3n-3 1.0 1.0 0.9 0.9 0.1 F=0.9, P=0.44 0.6 0.5 0.4 0.5 0.1 F=1.25, P=0.35 
18:2n-6 9.7 8.8a 11.2b 11.4b 0.4 F=136.9 *** 6.4 4.8 6.0 6.8 0.4 F=3.0, P=0.12 
18:1 37.9 30.1a 41.4b 43.9c 2.1 F=475.1 *** 34.8 31.1a 37.9b 40.7c 1.4 F=116.1 *** 
18:0 7.8 7.4a 9.2b 8.9b 0.3 F=94.3 *** 11.5 10.6a 12.9b 11.8ab 0.4 F=14.1 ** 
16:0 26.1 26.9 25.8 25.7 0.2 F=3.9, P=0.08 27.8 30.8 31.3 31.0 0.4 F=0.2, P=0.85 
SFA 38.5 39.3a 37.3b 36.5b 0.5 F=10.8 * 42.9 45.5 46.9 45.1 0.6 F=0.7, P=0.53 
MUFA 45.7 37.7a 45.0b 47.3c 1.5 F=153.3 *** 40.0 37.9a 41.3b 44.1c 0.9 F=47.6 *** 
PUFA 11.0 11.7a 14.0b 14.3b 0.4 F=60.2 *** 8.5 6.2 7.1 8.4 0.5 F=2.6, 0.15 
LC-PUFA 4.7 11.4a 3.8b 2.0b 1.5 F=57.2 *** 8.6 10.4a 4.7b 2.4c 1.2 F=349.0 *** 
Total n-3 4.3 11.9a 4.4b 2.7b 1.5 F=54.0 *** 8.6 9.7a 4.1b 2.6c 1.2 F=361.0 *** 
Total n-6  11.4 11.2a 13.4b 13.5b 0.5 F=92.0 *** 8.5 6.8 7.7 8.2 0.4  F=2.3, P=0.19 
^ Please refer to Table 1 for details. 
P SEM, Pooled standard error mean 
P<0.001***  P<0.01**  P<0.05* 
One-way ANOVA df 2,6, post-hoc Tukey's HSD 
Percentage data were arcsine transformed prior to analysis  
Any values <0.01 are reported as 0.1; NA, Not analysed; ND, Not detected 
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Figure 1 (a-d)  
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Figure 2 (a-h)  
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Figure 3 (a-f) 
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